Investors in Israel

Israel G-Tek LLC is an investment firm specializing in fund of funds and direct investments. For direct investments, the firm makes investments in angel, early, and mature stages. The firm seeks investments in greentech, energy efficiency, water and waste water management, alternative energy including solar, geothermal, and wind; water including filtering, recycling, and irrigation; and waste management including collection and recycling. It primarily invests in Israel. Israel G-Tek LLC is based in Miami, Florida.

Israel Growth Partners (IGP) is a growth capital investment firm established in 2014, headquartered in Herzliya, Israel. The firm specializes in providing growth capital and strategic guidance to Israeli-related technology companies at the growth stage, aiming to support strong management teams in building large global companies and achieving category leadership. IGP manages approximately $800 million in assets across three funds and has invested in 22 portfolio companies, with an average check size of $19 million at entry. The firm has achieved eight exits, including two IPOs, and has a team of seven members.

Israel Infrastructure Management provides private equity funding for infrastructure projects. The Company invests in strategic projects in energy, transportation, and construction sectors throughout the world.

Israel Investment Fund Group, LLC is a venture capital firm specializing to invest in startups, early stage companies and in assets. The firm invest in biotech, media and technology, real estate, renewable and water technology, healthcare and medical technology, and in cybersecurity. The firm only invest in Israel. Israel Investment Fund Group, LLC is headquartered in Beverly Hills, California.

Bridges Israel is an impact investment fund that focuses on investing in Israeli businesses to achieve competitive financial returns alongside significant, measurable social and environmental impact. The fund is based in Kibbutz Glil Yam, Israel.

Claridge Israel L.P. is a private equity firm and venture capital firm specializing in late venture, growth capital, management led later stage and emerging growth investments. The firm primarily invests in innovative companies with a technological advantage and infrastructure. The firms considers investment in Israel, North America, Europe, and Asia. It typically invests between $10 million and $40 million in one or a series of investments over time. The firm takes minority or majority equity stakes in its investments but prefers significant minority equity interests. Claridge Israel L.P. is headquartered in Herzliya Pituach, Israel.

Founded by Leon Recanati in 2003, GlenRock leverages a unique combination of private equity funding, multidisciplinary in-house expertise, and unmatched access to quality dealflow.

Founded in 1993, Gemini Israel Ventures is a pioneering venture capital firm specializing in early and seed-stage investments in technology companies. With over $750 million in assets under management across five funds, Gemini focuses on sectors such as mobile, digital media, enterprise software, online services, and semiconductors. The firm has a strong track record, with 30 mergers and acquisitions (M&A) and initial public offerings (IPOs) to its name. Gemini is known for its commitment to fostering innovation and growth through collaboration, making daring investment decisions, and leveraging past operational experience to assist portfolio companies.

Established in 1997, Vertex Ventures Israel is one of Israel's pioneering and most successful venture capital firms, managing over $1.4 billion in assets. The firm specializes in early-stage investments, focusing on Seed to Series B rounds, and has supported more than 150 companies across various sectors, including enterprise SaaS, cybersecurity, artificial intelligence, and fintech. Notable portfolio companies include Waze, CyberArk, and SolarEdge. Vertex Ventures Israel is part of the Vertex Global Network, which extends its reach beyond Israel to markets in Silicon Valley, China, Singapore, and India, providing portfolio companies with valuable resources and connections to maximize their growth potential.

We invest in Israeli founders in companies with early growth traction and initial revenues.

ALIVE is a pioneering mid-to-late stage HealthTech fund based in Israel, dedicated to accelerating the growth of innovative healthcare technologies. By leveraging an exclusive ecosystem of strategic partners—including leading hospital chains, health maintenance organizations (HMOs), and financial institutions—ALIVE supports portfolio companies in their clinical and commercial expansion. This collaborative approach enables ALIVE to deliver a capital-efficient model for HealthTech investors, offering high rewards with relatively low over a condensed investment journey of 3-5 years. The fund focuses on companies with the highest potential to improve the quality of life for millions of people, emphasizing in-depth understanding of clinical workflows, proven hands-on guidance, and product-market fit validation under challenging health economics and evolving market trends.

We are Venture Capital supporting visionary founders and offer them a bridge – both financially and strategically – towards scaling up.Israel has a solid track record of being an incubator of innovation that pioneers global industries and successful, highly valuable and profitable companies.Yet, in the start-up curve, most companies “get stuck” in the “death valley” between Seed and Round A. Those companies need a “capital bridge” in order to move on to the next milestone.At SIBF, we support visionary founders and offer them a bridge – both financially and strategically – towards scaling up.We identify companies with unique potential and breakthrough technologies, invest in them, and lead them hand-in-hand to the next stage.We combine our expertise, strategy, and connections with hands-on experience that will ensure that our tech companies are expertly run.We identify weaknesses and advantages, analyze challenges and potential markets, and create a winning strategy.

We invest in Israeli and Israeli-related exceptional entrepreneurs, from early-stage to Seed and Series A rounds. We are looking for startups who disrupt markets by using deep technology, creating new business models, and featuring entrepreneurial teams in digital health, fintech, insurance, computer vision, and artificial intelligence.

OTV is a venture capital firm specializing in digital health investments, focusing on mid-growth stage startups that aim to make a significant impact on global health. Founded in 2015, OTV has collectively generated over $4 billion in exit revenue over the last 10 years. The firm's portfolio includes companies such as TytoCare, Lemonaid Health, Emedgene, Scopio, and Donisi Health. OTV's mission is to identify and support entrepreneurs with innovative, disruptive ideas in the digital health arena, enabling them to build successful, impactful companies. The firm has offices in New York, USA, and Tel Aviv, Israel, and has expanded into the Asia Pacific region with a new office in Shanghai, China.

Digital Transformation Capital Partners GmbH (DTCP) is a specialist investment firm focused on driving digital transformation across various sectors. With over 50 investments and more than 17 successful exits, DTCP manages assets totaling €3 billion. The firm operates through two primary investment strategies: Infra and Growth. The Infra strategy specializes in digital infrastructure investments within the European mid-market, focusing on developing and operating essential assets like data centers, mobile towers, and fiber networks. The Growth strategy partners with top enterprise SaaS entrepreneurs in Europe, the US, and Israel, concentrating on growth-stage companies in sectors such as Cybersecurity, Vertical SaaS, DevOps, Cloud, AI, and Robotics. DTCP's portfolio includes notable companies like Arctic Wolf, Cellnex NL, Cognigy, Community Fibre, Dexory, GreenScale, LeanIX, maincubes, Quantum Systems, and Signavio. The firm's approach is centered on identifying and investing in transformative sectors where digital advancements lead to lasting impact and growth.

We invest in early stage cyber security and enterprise software companies with Israeli founders. How early? As early as it gets.

Team8 is a global venture group specializing in the creation and investment of companies within enterprise technologies, cybersecurity, artificial intelligence (AI), and fintech sectors. Founded in 2014 by former leaders of Israel's elite intelligence unit 8200, Team8 integrates an in-house company-building team with a community of C-level executives, known as the "Village," to drive innovation and accelerate the success of its portfolio companies. This collaborative model has led to the establishment of 20 companies and investments in 21 others, with typical investments ranging from $5-10 million per startup. Notable achievements include the successful exits of companies like Sygnia, Hysolate, Illusive Networks, and Claroty. In March 2024, Team8 raised $500 million to invest in startups related to cyber, data infrastructure, fintech, digital health, and AI, bringing its total funds under management to over $1 billion.